Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Slifstein

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Psychopharmacology|November 28, 2019
Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [<sup>11</sup>C]-(+)-PHNOMark Slifstein, Anissa Abi-Dargham, Ragy R Girgis, et al.
Psychopharmacology|January 14, 2023
Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetineDaniel R Rosell, Mark Slifstein, Judy Thompson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 14, 2018
Cerebral serotonin transporter measurements with [<sup>11</sup>C]DASB: A review on acquisition and preprocessing across 21 PET centresMartin Nørgaard, Melanie Ganz, Claus Svarer, et al.
Psychopharmacology|June 24, 2020
Amphetamine-induced striatal dopamine release in schizotypal personality disorderJudy L Thompson, Daniel R Rosell, Mark Slifstein, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Auditory and Visual Thalamocortical Connectivity Alterations in Unmedicated People with Schizophrenia: An Individualized Sensory Thalamic Localization and Resting-State Functional Connectivity StudyJohn C Williams, Philip N Tubiolo, Roberto B Gil, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 8, 2025
Auditory and Visual Thalamocortical Connectivity Alterations in Unmedicated People With Schizophrenia: An Individualized Sensory Thalamic Localization and Resting-State Functional Connectivity StudyJohn C Williams, Philip N Tubiolo, Roberto B Gil, et al.
JAMA Psychiatry|February 5, 2015
Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging studyMark Slifstein, Elsmarieke van de Giessen, Jared Van Snellenberg, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Translational Evidence for Dopaminergic Rewiring of the Basal Ganglia in Persons with SchizophreniaPhilip N Tubiolo, John C Williams, Roberto B Gil, et al.
Schizophrenia Bulletin|August 23, 2021
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for SchizophreniaAnissa Abi-Dargham, Jonathan A Javitch, Mark Slifstein, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 24, 2007
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsRobert B Innis, Vincent J Cunningham, Jacques Delforge, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Psychopharmacology|November 28, 2019
Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [<sup>11</sup>C]-(+)-PHNOMark Slifstein, Anissa Abi-Dargham, Ragy R Girgis, et al.
Psychopharmacology|January 14, 2023
Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetineDaniel R Rosell, Mark Slifstein, Judy Thompson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 14, 2018
Cerebral serotonin transporter measurements with [<sup>11</sup>C]DASB: A review on acquisition and preprocessing across 21 PET centresMartin Nørgaard, Melanie Ganz, Claus Svarer, et al.
Psychopharmacology|June 24, 2020
Amphetamine-induced striatal dopamine release in schizotypal personality disorderJudy L Thompson, Daniel R Rosell, Mark Slifstein, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Auditory and Visual Thalamocortical Connectivity Alterations in Unmedicated People with Schizophrenia: An Individualized Sensory Thalamic Localization and Resting-State Functional Connectivity StudyJohn C Williams, Philip N Tubiolo, Roberto B Gil, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 8, 2025
Auditory and Visual Thalamocortical Connectivity Alterations in Unmedicated People With Schizophrenia: An Individualized Sensory Thalamic Localization and Resting-State Functional Connectivity StudyJohn C Williams, Philip N Tubiolo, Roberto B Gil, et al.
JAMA Psychiatry|February 5, 2015
Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging studyMark Slifstein, Elsmarieke van de Giessen, Jared Van Snellenberg, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Translational Evidence for Dopaminergic Rewiring of the Basal Ganglia in Persons with SchizophreniaPhilip N Tubiolo, John C Williams, Roberto B Gil, et al.
Schizophrenia Bulletin|August 23, 2021
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for SchizophreniaAnissa Abi-Dargham, Jonathan A Javitch, Mark Slifstein, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 24, 2007
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsRobert B Innis, Vincent J Cunningham, Jacques Delforge, et al.
Pageof 14